We also noticed a higher burden of P/LP variants across known cancer predisposition (class 1–2; P = 3.9 × 10−4) and cancer-associated genes (class 1–3) was associated with cancer status in wildtype TP53 carriers (P = 2.3 × 10−3; Supplementary Fig. S4). The gene discussed is TP53; the disease is cancer.